Johnson Anne Nagengast 4
4 · ATAI Life Sciences N.V. · Filed Apr 4, 2024
Insider Transaction Report
Form 4
Johnson Anne Nagengast
Chief Financial Officer
Transactions
- Sale
Common Shares
2024-04-02$1.85/sh−27,410$50,709→ 73,590 total
Footnotes (1)
- [F1]Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.